Teruo Kitagawa

3.5k total citations
108 papers, 2.6k citations indexed

About

Teruo Kitagawa is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Teruo Kitagawa has authored 108 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 32 papers in Physiology and 25 papers in Clinical Biochemistry. Recurrent topics in Teruo Kitagawa's work include Lysosomal Storage Disorders Research (26 papers), Metabolism and Genetic Disorders (25 papers) and Diabetes and associated disorders (16 papers). Teruo Kitagawa is often cited by papers focused on Lysosomal Storage Disorders Research (26 papers), Metabolism and Genetic Disorders (25 papers) and Diabetes and associated disorders (16 papers). Teruo Kitagawa collaborates with scholars based in Japan, United States and United Kingdom. Teruo Kitagawa's co-authors include Misao Ōwada, Tatsuhiko Urakami, Takeshi Sakiyama, Kuniaki Yamauchi, Ken Suzuki, Toya Ohashi, Naoko Tajima, Kikumaro Aoki, Nobuyuki Ishige and Kensuke Harada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Teruo Kitagawa

105 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teruo Kitagawa Japan 25 1.1k 715 632 590 507 108 2.6k
Shimon Moses Israel 27 650 0.6× 511 0.7× 169 0.3× 688 1.2× 205 0.4× 100 2.5k
B. Kristiansson Sweden 30 335 0.3× 1.3k 1.8× 127 0.2× 532 0.9× 599 1.2× 81 2.7k
George Hug United States 24 512 0.5× 626 0.9× 175 0.3× 204 0.3× 675 1.3× 76 1.9k
Haruo Shintaku Japan 25 698 0.6× 777 1.1× 125 0.2× 157 0.3× 693 1.4× 116 2.1k
Anthony G.W. Norden United Kingdom 31 429 0.4× 1.2k 1.7× 246 0.4× 133 0.2× 145 0.3× 66 3.0k
Georges Berghe Belgium 23 290 0.3× 1.4k 1.9× 243 0.4× 187 0.3× 358 0.7× 46 2.1k
Carlo Pesce Italy 28 308 0.3× 794 1.1× 460 0.7× 176 0.3× 286 0.6× 84 2.4k
Masahiro Nishi Japan 29 495 0.5× 678 0.9× 554 0.9× 475 0.8× 109 0.2× 101 2.3k
Osamu Sakamoto Japan 25 372 0.3× 815 1.1× 69 0.1× 217 0.4× 941 1.9× 109 2.2k
Alexey Polonikov Russia 26 471 0.4× 834 1.2× 317 0.5× 344 0.6× 65 0.1× 171 2.3k

Countries citing papers authored by Teruo Kitagawa

Since Specialization
Citations

This map shows the geographic impact of Teruo Kitagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teruo Kitagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teruo Kitagawa more than expected).

Fields of papers citing papers by Teruo Kitagawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teruo Kitagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teruo Kitagawa. The network helps show where Teruo Kitagawa may publish in the future.

Co-authorship network of co-authors of Teruo Kitagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Teruo Kitagawa. A scholar is included among the top collaborators of Teruo Kitagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teruo Kitagawa. Teruo Kitagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuji‐Hosokawa, Atsumi, Kaoru Konishi, Makoto Ono, et al.. (2015). Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study. BMC Pediatrics. 15(1). 209–209. 34 indexed citations
2.
Yata, Nahoko, Osamu Uemura, Masataka Honda, et al.. (2013). Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays. Clinical and Experimental Nephrology. 17(6). 872–876. 14 indexed citations
3.
Kobayashi, Hiroshi, Yohta Shimada, Yoshikatsu Eto, et al.. (2011). Minimum requirement of donor cells to reduce the glycolipid storage following bone marrow transplantation in a murine model of Fabry disease. The Journal of Gene Medicine. 13(5). 262–268. 8 indexed citations
4.
Togawa, Tadayasu, Takashi Kodama, Toshihiro Suzuki, et al.. (2010). Plasma globotriaosylsphingosine as a biomarker of Fabry disease. Molecular Genetics and Metabolism. 100(3). 257–261. 118 indexed citations
5.
Hwu, Wuh‐Liang, Yin‐Hsiu Chien, Ni‐Chung Lee, et al.. (2009). Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A). Human Mutation. 30(10). 1397–1405. 263 indexed citations
6.
Kitagawa, Teruo, Ken Suzuki, Nobuyuki Ishige, et al.. (2008). Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes. Pediatric Nephrology. 23(9). 1461–1471. 16 indexed citations
7.
Shintaku, Haruo, Shigeo Kure, Toshihiro Ohura, et al.. (2005). Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. 7(4). 301–304. 185 indexed citations
8.
Kitagawa, Teruo, Nobuyuki Ishige, Ken Suzuki, et al.. (2005). Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry. Molecular Genetics and Metabolism. 85(3). 196–202. 48 indexed citations
9.
Kaneko, Kazunari, Yoshiyuki Ohtomo, Toshiaki Shimizu, et al.. (2002). Low Prevalence of Hypercalciuria in Japanese Children. ˜The œNephron journals/Nephron journals. 91(3). 439–443. 24 indexed citations
10.
Ōwada, Misao, Kikumaro Aoki, & Teruo Kitagawa. (2000). Taste preferences and feeding behaviour in children with phenylketonuria on a semisynthetic diet. European Journal of Pediatrics. 159(11). 846–850. 20 indexed citations
11.
Pugia, Michael J., et al.. (2000). Screening for Proteinuria in Japanese Schoolchildren: a New Approach. Clinical Chemistry and Laboratory Medicine (CCLM). 38(10). 975–982. 9 indexed citations
12.
Kasuga, Nobuyo, et al.. (1992). Relationship between Mortality Status of Children with IDDM and Regional Characteristics. 35(5). 391–396. 3 indexed citations
13.
Kasuga, Nobuyo, et al.. (1991). Relationship between Mortality Status of Children with IDDM and Medical Infrastructures. 34(1). 31–36. 2 indexed citations
14.
Ōwada, Misao, et al.. (1991). Autosomal Recessive Polycystic Kidney in Rats. ˜The œNephron journals/Nephron journals. 59(4). 637–640. 9 indexed citations
15.
Tajima, Naoko & Teruo Kitagawa. (1990). Procedures to Achieve 97.6% Ascertainment of the Mortality Status of IDDM Patients in a Nationwide Epidemiologic Study. 33(1). 19–26. 1 indexed citations
16.
Kitagawa, Teruo, et al.. (1989). High Urinary Levels of Human Growth Hormone in Children with Renal Tubular Dysfunction. ˜The œNephron journals/Nephron journals. 51(4). 561–562. 7 indexed citations
17.
Sakiyama, Takeshi, Kenichi Horinouchi, Akira Akatsuka, et al.. (1989). Clinico-Biochemical and Molecular Studies of Purine Nucleoside Phosphorylase Deficiency. Advances in experimental medicine and biology. 253A. 73–79. 4 indexed citations
18.
Kitagawa, Teruo, Misao Ōwada, Kikumaro Aoki, et al.. (1987). Treatment of Phenylketonuria with a Formula Consisting ofLow-Phenylalanine Peptide. Enzyme. 38(1-4). 321–327. 14 indexed citations
19.
Kitagawa, Teruo, Itsuro Hibi, Øystein Aagenæs, et al.. (1984). A Comparative Study on the Epidemiology of IDDM Between Japan, Norway, Israel and the United States. Pediatrics International. 26(3). 275–281. 14 indexed citations
20.
Kitagawa, Teruo. (1980). Neonatal Mass‐Screening for Inborn Errors of Metabolism in Japan. Pediatrics International. 24(1). 83–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shimon Moses Breakdown of academic impact, for papers by B. Kristiansson Breakdown of academic impact, for papers by George Hug Breakdown of academic impact, for papers by Haruo Shintaku Breakdown of academic impact, for papers by Anthony G.W. Norden Breakdown of academic impact, for papers by Georges Berghe Breakdown of academic impact, for papers by Carlo Pesce Breakdown of academic impact, for papers by Masahiro Nishi Breakdown of academic impact, for papers by Osamu Sakamoto Breakdown of academic impact, for papers by Alexey Polonikov
Rankless by CCL
2026